203 related articles for article (PubMed ID: 21444796)
1. Crystal structure of human natural cytotoxicity receptor NKp30 and identification of its ligand binding site.
Joyce MG; Tran P; Zhuravleva MA; Jaw J; Colonna M; Sun PD
Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6223-8. PubMed ID: 21444796
[TBL] [Abstract][Full Text] [Related]
2. Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6.
Li Y; Wang Q; Mariuzza RA
J Exp Med; 2011 Apr; 208(4):703-14. PubMed ID: 21422170
[TBL] [Abstract][Full Text] [Related]
3. Expression, crystallization and X-ray diffraction analysis of a complex between B7-H6, a tumor cell ligand for the natural cytotoxicity receptor NKp30, and an inhibitory antibody.
Xu X; Li Y; Gauthier L; Chen Q; Vivier E; Mariuzza RA
Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):697-701. PubMed ID: 26057798
[TBL] [Abstract][Full Text] [Related]
4. Structural Insights into the Inhibitory Mechanism of an Antibody against B7-H6, a Stress-Induced Cellular Ligand for the Natural Killer Cell Receptor NKp30.
Xu X; Narni-Mancinelli E; Cantoni C; Li Y; Guia S; Gauthier L; Chen Q; Moretta A; Vély F; Eisenstein E; Rangarajan S; Vivier E; Mariuzza RA
J Mol Biol; 2016 Nov; 428(22):4457-4466. PubMed ID: 27663271
[TBL] [Abstract][Full Text] [Related]
5. Homo-oligomerization of the activating natural killer cell receptor NKp30 ectodomain increases its binding affinity for cellular ligands.
Herrmann J; Berberich H; Hartmann J; Beyer S; Davies K; Koch J
J Biol Chem; 2014 Jan; 289(2):765-77. PubMed ID: 24275655
[TBL] [Abstract][Full Text] [Related]
6. Secreted Ligands of the NK Cell Receptor NKp30: B7-H6 Is in Contrast to BAG6 Only Marginally Released via Extracellular Vesicles.
Ponath V; Hoffmann N; Bergmann L; Mäder C; Alashkar Alhamwe B; Preußer C; Pogge von Strandmann E
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671836
[TBL] [Abstract][Full Text] [Related]
7. The stalk domain and the glycosylation status of the activating natural killer cell receptor NKp30 are important for ligand binding.
Hartmann J; Tran TV; Kaudeer J; Oberle K; Herrmann J; Quagliano I; Abel T; Cohnen A; Gatterdam V; Jacobs A; Wollscheid B; Tampé R; Watzl C; Diefenbach A; Koch J
J Biol Chem; 2012 Sep; 287(37):31527-39. PubMed ID: 22807449
[TBL] [Abstract][Full Text] [Related]
8. A soluble fragment of the tumor antigen BCL2-associated athanogene 6 (BAG-6) is essential and sufficient for inhibition of NKp30 receptor-dependent cytotoxicity of natural killer cells.
Binici J; Hartmann J; Herrmann J; Schreiber C; Beyer S; Güler G; Vogel V; Tumulka F; Abele R; Mäntele W; Koch J
J Biol Chem; 2013 Nov; 288(48):34295-303. PubMed ID: 24133212
[TBL] [Abstract][Full Text] [Related]
9. Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin.
Jarahian M; Fiedler M; Cohnen A; Djandji D; Hämmerling GJ; Gati C; Cerwenka A; Turner PC; Moyer RW; Watzl C; Hengel H; Momburg F
PLoS Pathog; 2011 Aug; 7(8):e1002195. PubMed ID: 21901096
[TBL] [Abstract][Full Text] [Related]
10. B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors.
Kaifu T; Escalière B; Gastinel LN; Vivier E; Baratin M
Cell Mol Life Sci; 2011 Nov; 68(21):3531-9. PubMed ID: 21877119
[TBL] [Abstract][Full Text] [Related]
11. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans.
Brandt CS; Baratin M; Yi EC; Kennedy J; Gao Z; Fox B; Haldeman B; Ostrander CD; Kaifu T; Chabannon C; Moretta A; West R; Xu W; Vivier E; Levin SD
J Exp Med; 2009 Jul; 206(7):1495-503. PubMed ID: 19528259
[TBL] [Abstract][Full Text] [Related]
12. Expression analysis of the ligands for the Natural Killer cell receptors NKp30 and NKp44.
Byrd A; Hoffmann SC; Jarahian M; Momburg F; Watzl C
PLoS One; 2007 Dec; 2(12):e1339. PubMed ID: 18092004
[TBL] [Abstract][Full Text] [Related]
13. Mimicking an induced self phenotype by coating lymphomas with the NKp30 ligand B7-H6 promotes NK cell cytotoxicity.
Kellner C; Maurer T; Hallack D; Repp R; van de Winkel JG; Parren PW; Valerius T; Humpe A; Gramatzki M; Peipp M
J Immunol; 2012 Nov; 189(10):5037-46. PubMed ID: 23066150
[TBL] [Abstract][Full Text] [Related]
14. The Stalk Domain of NKp30 Contributes to Ligand Binding and Signaling of a Preassembled NKp30-CD3ζ Complex.
Memmer S; Weil S; Beyer S; Zöller T; Peters E; Hartmann J; Steinle A; Koch J
J Biol Chem; 2016 Dec; 291(49):25427-25438. PubMed ID: 27754869
[TBL] [Abstract][Full Text] [Related]
15. Engineering a natural ligand-based CAR: directed evolution of the stress-receptor NKp30.
Butler SE; Brog RA; Chang CH; Sentman CL; Huang YH; Ackerman ME
Cancer Immunol Immunother; 2022 Jan; 71(1):165-176. PubMed ID: 34046711
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the human natural killer (NK) cell activating receptor NKp46 reveals structural relationship to other leukocyte receptor complex immunoreceptors.
Foster CE; Colonna M; Sun PD
J Biol Chem; 2003 Nov; 278(46):46081-6. PubMed ID: 12960161
[TBL] [Abstract][Full Text] [Related]
17. Affinity Maturation of the Natural Ligand (B7-H6) for Natural Cytotoxicity Receptor NKp30 by Yeast Surface Display.
Zielonka S; Krah S; Arras P; Lipinski B; Zimmermann J; Boje AS; Klausz K; Peipp M; Pekar L
Methods Mol Biol; 2023; 2681():231-248. PubMed ID: 37405651
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional NK Cell-Engaging Antibodies Targeting EGFR and NKp30 Elicit Efficient Tumor Cell Killing and Proinflammatory Cytokine Release.
Klausz K; Pekar L; Boje AS; Gehlert CL; Krohn S; Gupta T; Xiao Y; Krah S; Zaynagetdinov R; Lipinski B; Toleikis L; Poetzsch S; Rabinovich B; Peipp M; Zielonka S
J Immunol; 2022 Nov; 209(9):1724-1735. PubMed ID: 36104113
[TBL] [Abstract][Full Text] [Related]
19. Identification, molecular cloning and functional characterization of NKp46 and NKp30 natural cytotoxicity receptors in Macaca fascicularis NK cells.
De Maria A; Biassoni R; Fogli M; Rizzi M; Cantoni C; Costa P; Conte R; Mavilio D; Ensoli B; Cafaro A; Moretta A; Moretta L
Eur J Immunol; 2001 Dec; 31(12):3546-56. PubMed ID: 11745374
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of the activating NKp30 ligand B7-H6 by HDAC inhibitors impairs tumor cell recognition by NK cells.
Fiegler N; Textor S; Arnold A; Rölle A; Oehme I; Breuhahn K; Moldenhauer G; Witzens-Harig M; Cerwenka A
Blood; 2013 Aug; 122(5):684-93. PubMed ID: 23801635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
